1 / 40

Hepatic Dysfunction During Pregnancy

Hepatic Dysfunction During Pregnancy. Ayman Mokhtar Kamaly, MD Professor of Anesthesiology kamaly3@hotmail.com. Most pregnant women are young & healthy.

dena
Download Presentation

Hepatic Dysfunction During Pregnancy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatic Dysfunction During Pregnancy Ayman Mokhtar Kamaly, MD Professor of Anesthesiology kamaly3@hotmail.com

  2. Most pregnant women are young & healthy. • Liver disease is a rare complication of pregnancy, but when it occurs it may be so dramatic & in a tragic fashion for both mother & infant.

  3. Abnormal liver tests occur in 3%-5% of pregnancies, with many potential causes:

  4. Normal liver in pregnancy • Physiological changes in pregnancy: • 40% increase in plasma volume, • Increase in CO & HR (peaks at 32 wks), • Hepatic Bl flow remains the same or even decreases (35% of CO in non-pregnant Vs 28% in pregnants).

  5. Abnormal LFT During Pregnancy ‘normal for pregnancy’ • AST • ALT • GGT • BIL • ALP • Triglycerides • Cholesterol • Transferrin • α1, α2 globulins 20% ↓ ↑ ↓ • Alb • Urea • Uric acid

  6. (I) Liver Diseases Unique to Pregnancy

  7. Hyperemesis Gravidarum (HG) • Occurs in 0.3% of pregnancies (1st trimester), • Sever enough to indicate IV hydration, • Risk factors: • Hyperthyroidism, • Molar pregnancy, • Pre-existing DM, • Multiple pregnancies.

  8. LFT: • Mild ↑ Bil (< 4mg%), related to malnutrition & impaired excretion of Bil. • ALP ↑ twice N. • AST/ALT ↑ 20-fold • Biopsy:Histological normal. • Management: Rehydration, nutrition, antiemetics (± steroids).

  9. Intrahepatic Cholestasis of Pregnancy (ICP) • 3rd trimester disease (25-30 wks), • ↑bile acid [BA] (due to defective biliary transport)& Pruritus • Etiology: • Hormonal: Sex hormones have known cholestatic effects • Genetic: Certain ethnic groups (gene associated ICP) • Exogenous: seasonal, geographical, selenium deficiency

  10. Clinical Features and Diagnosis: • Pruritus: • Affects all parts of the body, • Worse @ night, • Severe cases→ patient may be suicidal. • ObstructiveJaundice: • 2-4 wks post pruritus (20-60% of pts.), • Pale stools & dark urine, • Diarrhea or steatorrhea, • Sudden fetal death, (due to ↑ fetal levels of BA).

  11. Labs (= Biliary obst): • ↑ Bil. (< 5 mg%) • ↑ ALP x 4 • ↑ ALT/AST: 2-10 fold • ↑ B.A.(most specific): 10-100 fold.

  12. Management: • Symptomatic therapy for mother + close monitoring & early delivery for the fetus. • Urso-deoxy-cholic acid (UDCA), 10-15 mg/kg (ttt of choice, completely safe) • Dexamethasone (12 mg/day for 1 wk) has the advantage of promoting fetal lung maturity • Cholestyramine, 10-12 g/day, • ProphylacticVitaminK.

  13. Outcome of pts. with ICP: • Pruritus & liver dysfunction resolveimmediately after delivery. • 45-70% recurrence in subsequent preg. or with oral contraceptives. • More liable to: • Gallstones, • Cholecystitis, • Hepatitis C, • Nonalcoholic pancreatitis, • Nonalcoholic cirrhosis.

  14. Preeclampsia and Eclampsia • Triad(hypertension + edema + proteinuria), • 5-10% of pregnancies in the 3rd trimester. • Liver involvement, always indicates severe preeclampsia. Etiology: • Placental hypoperfusion, with alteration of vasomotor tone, initiation of the coagulation cascade. • Nitric oxide has role, (upregulation of NO-synthase in normal pregnancy) • Imbalance of prostacyclin (PGI2) : thromboxane ratio increase systemic resistance.

  15. Hepatic Involvement: • Abnormal LFT in 20–30% of pts due to VC of hepatic vascular bed. • ALP (which is often elevated in pregnancy), may be further ↑, • Transaminases: 10-20 fold ↑, • Bilirubin < 5 mg%, • Complications: Subcapsular hematoma & rupture, infarction, & fulminant failure.

  16. Acute Hepatic Hemorrhage of the Rt Lobe with a Subcapsular Hematoma.

  17. Extensive necrosis throughout the Rt lobe with patchy necrosis in the Lt lobe

  18. Autopsy of a eclamptic woman shows multiple regions of hepatic infarction (pale zones).

  19. Unfortunately; No specific therapy for the hepatic involvement of preeclampsia, • It is only significant as an indicator of severity & need for immediate delivery to avoid eclampsia, hepatic rupture, or necrosis.

  20. HELLP Syndrome • HELLP is a complication of severe preeclampsia in 2-12% of cases (Hemolysis, Elevated Liver tests, & Low Platelet). • Key abnormalities: • V.C, platelet activation & consumption, • Thromboxane : Prostacyclin ratio alteration, • Activation of complement & coagulation cascade causing microangiopathic hemolytic anemia, • elevated liver enzymes with periportal and hepatic necrosis.

  21. Clinical Features & Diagnosis • There are no distinguished clinical features from preeclampsia (upper abdominal pain, nausea & vomiting, headache, edema, hypertension, and proteinuria). • Diagnosis requires the all 3 laboratory criteria: (1)Hemolysis (↑ indirect bil.), (2)↑Transaminases (10-20 fold + bil. < 5 mg%), (3) Thrombocytopenia(<150000).

  22. Classification of HELLP: • Tennessee System • Complete syndrome: • AST &/or ALT > 40 • Platelets <100000 • LDH > 600 IU/L • AST > 70 • Incomplete syndrome: • Any 1 or 2 of the above Mississippi Class System: • Class 1: Platelets < 50000 • Class 2: Platelets 50-100000 • Class 3: Platelets 100-150000 + Hemolysis + ↑liver enzymes (LDH>600)

  23. Differential Diagnoses of HELLP Thrombotic disorders • Thrombotic thrombocytopaenicpurpura, • Hemolytic uremic syndrome, • Sepsis & DIC, • Drug-induced hemolytic anemias. Consumptive disorders • Acute fatty liver of pregnancy, • Sepsis and DIC, • Hemorrhage. Others • Connective tissue disease, • SLE, • Antiphospholipid syndrome, • Procoagulant disorders.

  24. Management: • Hospitalization for stabilization (hypertension & DIC, seizure prophylaxis, fetal monitoring), • Delivery is the only definitive therapy (< 34 wk → steroids for lung & plt), • Outcome @ < 34 wk is better when steroids(dexamethasone, which cross the placenta) are used for 24-48 hr (main benefit is lung maturity & platelet count).

  25. Complications of HELLP • DIC, ARF, eclampsia, pulm edema, ARDS, • Indications for liver transplantation are very limited (persisting bleeding from a hepatic hematoma or hepatic rupture or liver failure - necrosis). • Hepatic hemorrhage or rupture due to exogenous trauma (abdominal palpation, convulsions, emesis & unnecessary transportation)

  26. Lt lobe Large subcapsular hematoma. Rt lobe has widespread necrosis a (heterogeneous, hypodense appearance), with “sparing” of Lt lobe.

  27. Acute Fatty Liver of Pregnancy (AFLP) • Rare fatal complication of preg. (3rd trimester). • ChCh: microvesicular fatty infiltration →encephalopathy & hepatic failure with up to 10% mortality. • Etiology: Enzyme mutation (mitochondria fatty acid oxidation) • 20% of babies for mothers with AFLP are +ve for the enzyme .

  28. Clinical Features and Diagnosis • 40%-50% of pts with AFLP are in their 1st preg, with twin. • Presentation: vary from asymptomatic, nonspecific symptoms, to fulminant liver failure. • Transaminases: 300-500, Bil. < 5 mg% • Presumptive diagnosis is made on compatible clinical and lab features. • Definitive diagnosis is histological.

  29. AFLP: Diffuse fatty infiltration (A): (low power), (B):(high power)

  30. Management: • Immediate termination of pregnancy, • Vaginal Vs CS according to INR (< 1.5) & plt (> 50000), Outcome: • before 1980, both maternal & fetal mortality were 85%, • With advance of supportive care, mortality went down to 7-18%.

  31. (II) Liver Diseases Occurring Coincidentally in a Pregnant Patient

  32. Viral Hepatitis • 40% of jaundice in pregnant women in USA. • Hepatitis A, B, C, D, E, Herpes, CMV, Epstein-Barr viruses. • Management of pt with acute viral hepatitis is supportive, • Viral hepatitis is NOTan indication for termination of pregnancy, caesarean section, or discouragement for breastfeeding

  33. Pregnants with -ve HBV antibodies, & @ high risk (e.g., +ve partner) can be vaccinated safely with little fetal risk. • HBV transmission is NOT transplacental, but only during delivery. • HCV mother to infant transmission is only 1-5%.

  34. Gallstones & Biliary Disease • Cholesterol secretion ↑ in the 2nd & 3rd trimesters > bile acids & phospholipids, → to supersaturated bile, • Surgery is indicated when not responding to conservative measure (1st trimester (risk of abortion), & in 3rd trimester (risk of prematurity) ideally: Laproscopic. • ERCP for impacted CBD stone (fluoroscopy minimization)

  35. (III) The Pregnant Patient with Chronic Liver Disease

  36. In HCV, aminotransferases may fall & viral RNA ↑ during pregnancy. • Unfortunately, the optimal management of pregnancy with cirrhosis and portal hypertension in the modern era of obstetrics is undefined. • Most patients with advanced cirrhosis are amenorrheic & infertile due to hypothalamic -pituitary dysfunction.

  37. B-blocker is indicated for Pts with large varices, despite fetal effects, • Acute variceal bleeding is managed endoscopically (as in non-preg), however; Vasopressin is contraindicated. • In Pts with known large varices, avoidance of CS is recommended to avoid ↑ in portal pressure.

  38. Conclusion

More Related